GCP Inspections: Corrective Measures For Adverse Findings Should Be Tested, US FDA Says

 
• By Sue Sutter
  
Derailed train
FDA wants to see processes in place to ensure that clinical trial operations don't go "off the rails" again. • Source: Alamy

More from Clinical Trials

More from R&D